EK1 是一种基于肽的冠状病毒 (CoV) 融合抑制剂,对多种冠状病毒具有广谱抑制作用。EK1 显示出显著增强的泛冠状病毒融合抑制活性。EK1 可有效抑制 SARS-CoV-2。EK1 可以与短 α-hCoV 和长 β-hCoV N 端七肽重复序列形成稳定的六螺旋束 (6HB) 结构。
产品信息
| 产品名称 | EK1 |
| 产品描述 | EK1 is a peptide-based coronavirus (CoV) fusion inhibitor with broad-spectrum inhibitory effects against multiple coronaviruses. EK1 shows significantly enhanced pan-coronavirus fusion inhibitory activity. EK1 effectively inhibits SARS-CoV-2. EK1 can form a stable six-helix bundle (6HB) structure with the short α-hCoV and long β-hCoV N-terminal heptad repeat sequences. |
| 生物活性 | EK1 is a peptide-based fusion inhibitor of coronaviruses (CoVs) with broad spectrum inhibition to a number of CoV species. EK1 shows substantially improved pan-CoV fusion inhibitory activity. EK1 potently inhibits SARS-CoV-2. EK1 can form a stable six-helix bundle (6HB) structure with both short α-hCoV and long β-hCoV N-terminal heptad repeats. |
| 序列缩写 | SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |


联系我们